TransCanna Holdings Inc. (CSE:TCAN, FSE:TH8) (“TransCanna” or the “Company”) announces that the holders of a promissory note in the principal amount of US$4,000,000 (the “Note”), that was issued in favour of the vendors of Lyfted Farms, Inc. (“Lyfted”) in connection with the recent acquisition by the Company of Lyfted, have exercised an option (the “Option”) pursuant to the terms of the Note to receive common shares of the Company (“Common Shares”) in settlement of US$500,000 principal amount of the Note.

A total of 550,504 Common Shares will be issued pursuant to the exercise of the Option at a deemed price of CDN$1.18 per share, after converting the principal amount being settled into Canadian dollars using the Bank of Canada indicative rate of exchange of US$1.00 = CDN$1.2992. The principal amount of the Note will be reduced to US$3,500,000 concurrent with the issuance of the Common Shares. The Common Shares issued in connection with the Option exercise will be subject to restrictions on trading in accordance with applicable securities laws and Canadian Securities Exchange policies.

“The exercise of the Option represents a great vote of confidence in the future of TransCanna,” commented Steve Giblin, President and CEO of TransCanna. “The noteholders who have elected to receive stock in exchange for debt either work for or are closely associated with TransCanna, and we appreciate their confidence in the success of our company.”

Bob Blink, Chief Executive Officer of Lyfted and a holder of the Note, shall receive 258,738 common shares of the Company pursuant to the exercise of the Option, which constitutes a “related party transaction” as defined under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The Company is relying on exemptions from the formal valuation and minority shareholder approval requirements provided in sections 5.5(b) and 5.7(a) of MI 61-101 on the basis that the Company’s common shares are not listed or quoted for trading on a prescribed stock exchange or stock market and that the fair market value of the transaction, insofar as it involves insiders, does not exceed 25% of the Company’s market capitalization. The Company will file a material change report in respect of the issuance of common shares as a result of the Option exercise, however, the material change report will not be filed 21 days prior to the issuance of the common shares as a result of the timing of the Option exercise.

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a California based, Canadian listed, company building Cannabis focused brands for the California lifestyle, through its wholly-owned California subsidiaries.

For further information, please visit the Company’s website at or email the Company at

On behalf of the Board of Directors
Steve Giblin

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.


Click here to connect with Transcanna Holdings Inc. (CSE:TCAN) for an Investor Presentation.


Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000. The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Each Unit is comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant is exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

Keep reading... Show less

AMP German Cannabis Group Inc. (” AMP “) (CSE: XCX ), ( Frankfurt : C4T ) (ISIN: CA00176G1028) and Aphria Inc.’s (” Aphria “) (TSX: APHA ) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (” CC Pharma “), have entered into a strategic agreement (the ” Co-Promotion Agreement “) covering joint marketing of sales for Aphria brand medical cannabis products for the German market.

The Co-Promotion Agreement is a collaboration contract between AMP and CC Pharma to sell the Aphria medical cannabis brand in Germany . In addition, AMP will organize with the support of CC Pharma, “information events” in Germany to market Aphria branded products to doctors and pharmacists.

Keep reading... Show less

HempFusion Wellness Inc. ( TSX:CBD.U ) ( FWB:8OO ) (“ HempFusion ” or the “ Company ”) is pleased to announce that it has been included in two leading cannabis & hemp-derived CBD focused exchange-traded funds (“ ETFs ”), AdvisorShares Pure US Cannabis ETF ( NYSE:MSOS ) and AdvisorShares Pure Cannabis ETF ( NYSE:YOLO ).

AdvisorShares is a leading sponsor of actively managed ETFs. Pure US Cannabis ETF (MSOS) is the only US-listed ETF dedicated solely to US cannabis exposure, with over US$616,000,000 in assets under management (“ AUM ”). Pure Cannabis ETF (YOLO) was the first US-based actively managed ETF focused on the global cannabis industry. YOLO and MSOS endeavor to achieve long-term capital growth by investing in some of the largest foreign and domestic cannabis and hemp-derived CBD companies. The two AdvisorShares ETFs have a combined AUM of over US$880,000,000 as of January 22, 2021.

Keep reading... Show less

Martha Stewart’s CBD for Pet line features science-backed, gourmet-flavored CBD soft-chews and oil drops for dogs and carries the NASC Quality Seal

Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC), a world-leading diversified cannabis, hemp, and vaporization device company, announced today the launch of Martha Stewart CBD for Pet a new line of scientifically-backed CBD wellness solutions for canines developed by Martha Stewart with her own beloved dogs in mind.

Keep reading... Show less